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Abstract 
Background.  Breast screening improves survival in women aged 50-70.  The relative 
benefits of screening in women over 70 are reduced but women up to age 80 may still 
benefit. In the UK the National Health Service provides screening by self referral to women 
>70. This research has investigated health care professionals’ (HCPs’) preferences for 
extending screening to older women and factors they consider when advising about 
screening.   
Materials and Methods: UK HCPs from breast or elderly care were recruited.  A 
questionnaire relating to screening in the >70s was administered.  A sample of respondents 
was also interviewed to give added insight. 
Results:  Questionnaires were distributed to 488 HCPs and 139 replies received, (29%).  A 
total of 26 professionals were also interviewed. Most felt the current system of self referral 
was under-utilised due to poor user awareness.   Predicted life expectancy, co-morbidity 
and patient preference were viewed as important factors influencing screening 
recommendation.  Chronological age was thought less important.  The present system was 
thought flawed, but there was little enthusiasm for extending screening due to perceived 
risks and reduced cost efficacy.  Some form of selectivity for fitter women was advocated.   
Conclusions: There was acceptance that fitter older women may benefit from screening 
whilst the less fit may be harmed suggesting that some form of selective invitation would be 
preferable to the present system but would be practically difficult and costly to administer.  
The present system of self referral was felt to be inadequate due to low levels of awareness 
and uptake.   
Key words: Breast cancer screening, treatment variation, discrete choice experiment, 
professional preferences. 
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Introduction 
The UK has inferior breast cancer outcomes compared to the European average partly due 
to more advanced stage at diagnosis, (1) (2). Older women account for one third of all UK 
breast cancers and lack of regular screening in this age group may be a significant factor in 
the inferior outcomes in this age group, (3). 
In the UK, the NHS Breast Screening Programme (NHSBSP) invites all women for triennial 
mammographic screening between 50 and 70 years of age.   Once a woman reaches 70, she 
may request continued screening.  Although mammographic breast screening reduces 
mortality from breast cancer by 25-39% in the screened age group, (4) in women >70 there 
is little direct evidence of benefit, (5), (6), (7).  Indirect evidence from cohort and modelling 
studies suggest that extending screening to women aged up to 80 may be beneficial.  
Certainly the incidence of breast cancer continues to increase with advancing age until age 
80 (8).  There is little doubt that the relative benefits of screening older women may be less 
and the risks greater due to the influence of competing causes of death and over-diagnosis 
which reduces the gain from early detection (9) (10).  However screening does result in the 
diagnosis of smaller, earlier stage cancers in older women (5) and roughly halves the 
mastectomy rate (11).  In fact mammography has increasing sensitivity and accuracy in older 
women due to reduced breast density in this age group which reduces the number of false 
positives and unnecessary biopsies (12). 
Health Care Professionals (HCPs) may be asked to advise about whether screening may be 
beneficial for an individual older woman.  Evidence suggests that physician advice may be of 
variable quality.  Studies in the USA suggest that women with chronic co-morbidity, who are 
likely to see HCPs regularly, are more likely to be advised to have mammograms (13) .  In 
another study, almost half of all women over 80 years referred for mammograms were in 
poor health and unlikely to benefit (14).   
The UK NHSBSP currently screens routinely to age 70 and beyond this, places the onus for 
seeking screening mammography with the patient. The American Cancer Society (15) 
suggests no upper age limit but advises screening as long as the patient is healthy (16). The 
International Society for Geriatric Oncology (SIOG) recommends screening be available up 
to 75 with individualised decision making beyond this based on patient preference, 
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physiological age and life expectancy (17).  In practice, this places the onus for decision 
making on the physician and such estimates of life expectancy can be difficult.  
The present study examines the views of specialist HCPs towards screening in older women 
(>70yrs), the current screening system and to whom it should be offered.  It draws upon 
summary findings from a quantitative survey as well as purposively selected qualitative 
interviews with HCPs.  The questionnaire included a discrete choice experiment where HCPs 
were given 23 scenarios based around women of varying ages and health statuses and 
asked to state whether they would advocate screening.  Their responses were analysed 
relative to predicted life expectancy of greater than 5 years (in line with SIOG and ACS 
recommendations).   
The aims were to establish:  whether HCPs are in favour of screening extension in the UK, to 
whom and how it should be offered and how accurately they can assess which women may 
benefit. 
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Materials and Methods: 
Postal Questionnaire Survey 
Research Ethics Committee approval was obtained.  A postal questionnaire was designed, 
based on a literature review and expert opinion of the study group.  It was mailed to HCPs 
with expertise in the field of breast cancer management or elderly care, identified from 3 
sources:   
(1) The UK Association of Breast Surgeons (ABS) membership database, (n=200),  
(2) The British Society of Geriatrics (BSG) membership database (n=200),  
(3) Local HCP in the North Trent Health Region: Surgeons, Oncologists, Screening 
Radiologists, and General Practitioners and Breast Care Nurses (n=88).   
No reminder was sent.  The questionnaire comprised 4 sections:  
(1) Respondent demographics, (age, sex, occupation, experience). 
(2) Questions relating to factors influencing breast screening recommendation in the over 
70s. 
(3) Statements about the current organisation of screening, with a Likert style grading of 
opinion. 
(4) A series of 23 hypothetical patient scenarios [Discrete Choice Experiment, (DCE)] (18), 
(19). 
These 23 patient scenarios described hypothetical older women who had asked for advice 
about whether they should continue attending screening. By peer consensus, five variables 
were selected for inclusion.  The variables included age group (50-70, 70-74, 75-80, 80-84 
and >85), co-morbidity (none, mild, moderate, severe), functional status (independent, mild, 
moderate or severe dependency), cognitive function (normal, mild, moderate, severe 
impairment) and breast cancer risk factors (normal, raised).  The questionnaire’s 23 
scenarios were randomly generated from the reduction of all possible combinations of the 
five variables levels generated by SPSS ‘Orthoplan’ software (640 potential scenarios) by 
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fractional factorial design (20). These scenarios were then categorised to place women into 
predicted life expectancy categories of <2, 2-5 and >5 years.  Current opinion is that women 
with a predicted life expectancy of over 5 years may benefit from screening, whereas those 
likely to survive for <2 years may not benefit (21).  The predicted life expectancy of each 
patient scenario was NOT shown to questionnaire respondents as this information would 
not be routinely available in normal practice.  
Clinicians were asked to indicate their screening preferences for each scenario as either: for 
breast screening; not for breast screening; or undecided. Multinomial logistic regression 
(MLR), in STATA v11 (22), with robust standard errors to allow for clustering by respondent 
was used to look for associations between the screening preference and clinical 
characteristics (age, co-morbidity, breast cancer risk, functional status and cognitive 
function). 
Qualitative Interviews  
At the end of the questionnaire participants were asked if they would consent to be 
interviewed about breast screening in the over 70s.  Interviews were digitally recorded and 
transcribed verbatim.  Recruitment ceased once data saturation had occurred.  Analysis 
followed the National Centre for Social Research ‘Framework’ approach to identify recurrent 
themes (23).  A thematic index was drawn up and applied to the data. Data was entered into 
thematic charts and examined to allow interpretation of the data and to identify any 
relationships between themes.  
Results 
One-hundred and thirty-nine of the 488 clinicians approached returned completed 
questionnaires (29% response rate): 63% male, 37% female; 58% surgeons, 19% 
geriatricians, 9% general practitioners (GPs),  3.6% breast radiologists, 1.4% breast clinicians, 
3.6% oncologists and 5% breast care nurses.  The median age was 49 years (range 30 to 66) 
with a median of 26 years post-qualification experience (range 6 to 41).  No reminder was 
sent. 
Of these, 52 consented to be interviewed (37%) and 26 were invited to interview (selection 
applied to ensure all HCP types were represented and interviews discontinued once 
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thematic saturation had occurred).   These included 11 breast surgeons, 3 geriatricians, 4 
GPs, 3 radiologists, 3 breast care nurses, 1 oncologists and 1 screening radiographer. 
The thematic frame categorised the data into four themes detailed below. The interview 
and questionnaire data are presented concurrently below and summarised in Figure 1 and 
Tables 1 and 2.   
1. iews regarding breast screening in the over 70s. 
HCPs were generally in favour of breast screening (non age specific).  A total of 83% 
(115/138) felt screening reduced the death rate from breast cancer and 55% (76/138) 
agreed that screening was cost effective.  Few, 8% (11/138) disagreed that screening was 
beneficial.  (Questions 1.1 and 1.2 in Table 1). 
With regards to screening older women, (questions 5.1-4, Table 1) opinion was mixed 
regarding whether women >70 derive as much benefit as women aged 50-69 (Q 5.1).  The 
majority felt screening should only be offered to the age range where it was cost effective 
(63%, 87/138, Q5.3).   However, there was also support for the idea that screening should 
be offered to any women over 50 if she was healthy enough to benefit, (68%,95/137,  Q 
5.2).   
These mixed attitudes to screening in older women were based on several factors when 
explored at interview including the general principal of equality of access and patient 
choice, increasing life expectancy and fitness in older age and the progressive increase in 
breast cancer risk with older age (Table 2).  However the effect of co-morbidity, frailty and 
cognitive decline were all viewed as important if HCPs were considering whether to advise 
continued attendance at screening and it was generally felt that if a woman was fit enough 
to benefit she should continue to be screened (Table 2).  Age alone was not rated as highly 
as co-morbidity when considering whether to screen (Figure 1).   Predicted life expectancy 
was rated as very important or important by 82% demonstrating HCP’s appreciation that 
this reflects overall health status and the most likely predictor of screening benefit.   
 
2. Benefits and risks of breast screening in older age  
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Both the interview and questionnaire data found almost all HCPS to have good knowledge 
of the benefits and risks of breast screening in older women.  Most were aware that 
screening can over diagnose cancer (59%,81/138 Q2.1), can cause psychological distress 
(64%,88/138, Q2.3) and result in unnecessary diagnostic procedures (69%, 95/138Q2.2).    
The burden of ‘over diagnosis’ and false-positive results and the impact of treatment of 
screen detected cancers that would not necessarily have affected the woman during her 
natural lifetime were felt to be more pressing in the older age group.   
Several HCPs held strong beliefs that screening should cease altogether when there were 
only marginal benefits to the woman, as it was neither cost effective or efficient and 
consequently ‘over burdened’ the service (Table 2). Older women with significant cognitive 
impairment, sufficient to render them unable to give informed consent should they need 
treatment, were one group where most HCPs would not recommend screening due to the 
marginal benefits. 
3. Perceived awareness of the current system for referral  
Most HCPs felt that the current system of voluntary self referral was not widely known 
among older women.  The majority of HCPs felt that older women were less breast aware 
than their younger counterparts, (80%,111/139, Q4.1) and were unaware of self referral for 
screening, (59%, 82/138, Q4.2).  HCPS also held the view that these women had poor 
knowledge about the benefits and risks of screening in older age and this impeded their 
ability to make an informed decision about screening (Table 2).  
Several HCPs also talked about the potential difficulties of explaining the risks versus 
benefits of breast screening to this older age group, as well as the controversy regarding the 
factors to consider in this decision-making process. Several HCPs argued that it was not 
currently a political imperative to publicise and promote the availability of breast screening 
to older women for fear of being ‘over burdened’ in a system that was currently struggling 
to cope.  Another concern was the perception that many older women mistakenly believe 
that because they were no longer invited to attend for breast screening, they inferred they 
must therefore no longer be at risk of developing breast cancer (Table 2).  
However, several HCPs raised the issue that even if there was an increased 
awareness campaign with increased information about the availability and risks and 
benefits of breast screening in older age, this would have very little impact on 
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uptake as such literature is rarely read (Table 2).  However this view may be overly 
negative as research has shown that educational initiatives do result in improved 
long term knowledge about screening in older women (24-25). 
 
4. Views towards the current and preferred system for screening referral   
The views of HCP about the current screening arrangements for the over 70s were explored 
and alternative strategies discussed.  In general there was little support for any potential 
strategy suggesting a degree of uncertainty about the optimal system.  The least favoured 
was a system of selective recall at the GPs’ discretion with only 10%, (14/138, Q3.2) 
favouring this option.  Similarly there was little support for the current system of self 
referral with only 35%, (48/136, Q3.4) agreeing with this system.  The most support was for 
some form of selective recall for women who remain in good health and therefore likely to 
benefit, balanced by a mechanism for restricting harm in those at risk of harm (58/139, 42%, 
Q3.1).   
The current system was viewed as working in favour of higher socio-economic groups; that 
women who continue to attend when reminders cease are drawn disproportionately from 
the ‘better educated’ rather than ‘disadvantaged’ sections of society (Table 2).   
However, although several problems were identified with the current system of self referral, 
there appeared to be little enthusiasm for screening models where the age invitation was 
simply extended to 80 years, (22%,31/139, Q3.3).  However applying selectivity was thought 
practically difficult to instigate.  The model of GPs selectively advising screening older 
women raised concerns regarding time, capacity and workload issues (Table 2).   
Without selectivity, concerns were for harms done to less fit women.  With selectivity some 
commented that this just introduced an additional, unnecessary barrier to access (Table 2). 
 
In summary, although HCPs were aware that there were currently several problems with the 
current system of voluntary self referral, namely access and uptake, there was no 
concordant opinion about how the system could be improved.   
5. Discrete Choice Experiment Results. 
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The 139 responders answered all 23 scenarios.  In 38.8% of scenarios responders’ 
preference was for breast screening, 49.7% not for breast screening, and 11.5% undecided.  
Table 3 summarizes the results by scenario.  Scenarios are displayed as individual rows.  This 
highlights a lack of consensus in clinicians’ preferences for some scenarios. An example is 
scenario 20 which describes a woman aged 80-84 with moderate co-morbidity, a raised 
breast cancer risk, moderate dependency and normal cognitive function. In this case, 41.7% 
of clinicians would prefer this woman to attend breast screening, 39.6% had a preference 
not for breast screening and 18.7% were undecided. Several other scenarios ‘split’ opinion 
(1, 4, 16 and 23) emphasizing the fact that in many cases clinicians would not give consistent 
advice and might benefit from guidance. 
Table 3 also illustrates that some clinicians adhere rigidly to their preferences despite the 
national policy for screening patients in this age group. For example, clinicians retain their 
preference for not screening in scenarios 15 and 23, where patients are aged 50-69 but with 
poorer levels of functioning.   
Responses were analysed across scenarios, to establish the impact of individual variables 
over clinicians’ preferences for breast screening.  A response of “undecided” was treated as 
the reference screening option and compared with “preference for breast screening” and 
“preference for not breast screening” using univariate and multivariate analysis.  
All five variables (age, co-morbidity, breast cancer risk, functional status and cognitive 
function) independently demonstrated a statistically significant association with screening 
preference (p<0.001). When all five variables were included a multivariate analysis the 
breast cancer risk variable was of marginal significance (p=0.061).  The results of the 
multivariate analysis with all five DCE variables are summarised in Table 4.   The results 
show “preference for not breast screening” over “undecided,” and for “undecided” over 
“preference for breast screening,” correlated positively with increasing patient age, co-
morbidity, functional dependency and cognitive impairment.   
Consistent with current screening guidelines, patient age appears to exert the greatest 
influence over preferences.  For example, other factors being equal, clinicians are over 
seventeen times more likely to prefer not to screen rather than being undecided, if a 
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woman is aged over 85, than if she is under 70 (p=<0.001). The DCE technique confirmed 
most clinicians’ preferences are consistent with evidence-based screening guidelines.  But in 
addition it permitted the discovery of several nuances: in particular how patient age, co-
morbidity and function impact on clinicians’ preferences.  Clinicians increasingly prefer not 
to screen with increasing patient age, increasing levels of co-morbidity, and increasing 
functional impairment.   
When clinician factors were incorporated into multivariate analysis alongside the other 
variables, clinician gender demonstrated some independent association with screening 
preferences with female HCPs half as likely as male HCPs to choose not to screen compared 
to being undecided (female vs. male clinician gender, relative risk preference for not 
screening vs. undecided 0.52, 95% CI 0.32-0.84, p=0.008).  
The majority of HCPs correctly selected women for screening in terms of their predicted life 
expectancy (if <2 years life expectancy screening will probably be of no benefit, and if over 5 
years, will probably be of benefit).  However in some scenarios, where patients were in the 
normal screening age (50-69) but unlikely to survive for long (scenarios 15 and 23), a 
significant minority still advocated screening (26.6 and 41% respectively).  Conversely, for 
some very healthy, much older women a significant minority would not advocate screening 
(scenario 1, 36.7% would not screen).   
Discussion 
The present study has provided valuable insight into the issues relating to screening in older 
women and how this is viewed by a range of UK health professionals working in the relevant 
disciplines of breast care and elderly care.  The results must be interpreted with a note of 
caution due to the overall response rate of 29%.  This partly reflects the fact that no 
reminders were sent out.  The response rate varied by category of HCP with breast surgeons 
responding at a satisfactory rate (response rate of 39%) compared to a poor response rate 
in geriatricians (13%).  It is likely that this reflects the fact that this group of professionals 
have little input into breast-related issues and probably felt that the questionnaire was of 
little relevance to their practice. 
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These data suggest that HCPs favoured offering breast screening to older women, but with 
some restriction based on likelihood of benefit.  There were themes of fairness and equality 
of access, increased fitness and life expectancy, tempered by an understanding of the 
relative reduction in benefit and increased harms with increasing age.  Whilst the 
questionnaire responses identified that HCPs did not rate age as the most important factor 
when asked directly but felt life expectancy was more critical, the discrete choice scenarios 
found age to be the most significant variable.  The discrete choice scenarios did not specify 
the likely life expectancy of each hypothetical patient, information which was not made 
available to the respondents.  It is therefore possible that had this information been 
available it would have been a more significant variable.  It does suggest that HCPs feel that 
life expectancy is most closely related to age rather than co-morbidity and frailty, which may 
not be the case.  This is further highlighted by the scenario responses where a younger but 
ill woman with a very short life expectancy generated a mixed opinion about screening as 
did a very fit woman in the oldest age group suggesting that age dominates the other 
variables.   
 
In all screening programs there are several risks which must be balanced against the 
potential benefits. Importantly these include the inevitable distress and discomfort for those 
women who are recalled for what subsequently proves to be benign disease and the 
problem of diagnosis of disease that will not affect a patient’s survival (9), (10).  This issue 
becomes increasingly important in older women and is the reason why the majority of 
national screening programs have an upper age limit.  Most HCP’s recognise that the upper 
limit in the UK (currently 70 and to be extended to 73 years) may exclude many women who 
could benefit, but also that any further extension may increase the risk of harm to some 
women.  The recommendation of SIOG for individual decision-making based on 
physiological age and life expectancy (17) , whilst theoretically supported was felt to pose 
practical difficulties.  These related to the time and resource implications of such 
assessments in a health system which is tightly regulated financially (the UK National Health 
Service).  Introduction of such a system for all older women would need to be cost effective 
which is unlikely to be the case in view of the increasing costs per life saved of screening in 
older individuals (26).  
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This study has increased our understanding of health care professionals’ preferences for the 
extension of breast screening to older women. Older women themselves feel strongly that  
screening should be offered to all women regardless of age or health (27).  However the 
majority of older women are unaware of any potential risks from screening (27) and so their 
preference for continued invitation is based on incomplete knowledge.  Giving older women 
enhanced, informed knowledge of screening availability and its potential risks, with access 
to HCPs to discuss individualised needs for screening may be the optimal way to improve 
the present situation in the UK and be associated with less harm than simply extending the 
age range still further.  This would be associated with financial costs but these could be kept 
to a minimum by engaging women themselves in the decision making process by providing 
more detailed information about screening benefits and harms and the fact that screening 
may not benefit women in poor health, who should consult their doctor to discuss their 
screening needs. Instead of being sent a screening invitation, women could be sent 
information to help them to consider whether to attend screening or not.  Those in 
excellent health and who still wish to attend would thus be reminded to do so.  All others 
would be directed to their doctor to discuss the risks and benefits of screening. 
 
This would place some additional workload on HCPs to advise such women, (which  raises 
concern amongst study respondents), but this work suggests that UK HCPs are generally 
skilled at identifying women who are likely to benefit from ongoing screening based on their 
age and health status.  Previous studies have suggested that some HCPs find it difficult to 
advise against screening in those for whom screening would have little benefit, presumably 
as this would involve implying the futility of screening in the face of a significantly reduced 
life expectancy (28).  This is a difficult and sensitive issue to discuss.  However the present 
study was based on hypothetical patient scenarios which may not reflect actual practice. 
Whilst our data would suggest that on the whole HCPs would make accurate assessments of 
the appropriateness of ongoing screening, this would need to be tested in the clinical 
setting.  Previous studies of actual screening advice by HCPs to older women have been less 
than encouraging. There is a tendency to advise screening to women who are seen 
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frequently by their doctors (13), usually because they are in poor health, rather than fitter 
women who rarely attend and a significant proportion, up to 50%, of older women referred 
for screening are deemed unlikely to benefit (14).   It is therefore clear that any such system 
which relied in part on the views of physicians about who is suitable for screening would 
need to be clinically tested and clear advice and guidance would need to be available to 
HCPs to ensure appropriate advice was given.  Such a system of informed choice supported 
by high quality HCP advice would potentially improve screening access and knowledge in 
older women, promote informed choice and reduce the harms of screening by selecting out 
women who might not benefit. 
 
The UK NHS Breast Screening Programme is extending the upper screening age to 73 over 
the next 3 years following a decision by the UK Government in 2007 (29) in an attempt to 
improve UK cancer outcomes which lag behind European averages (2).  This extension will 
be phased in across the UK by randomization, so some women will be offered screening in 
this age group, others not.  This will permit valuable comparative data to be collected.  In 
view of the lack of good quality data on the effects of screening in older women this data 
will be extremely valuable in addressing the issue of whether screening benefits older 
women.  Further trials are needed to define the characteristics of older women who will no 
longer benefit and until such data are available, older women should be encouraged to 
make an informed choice based on the best available evidence about whether they wish to 
attend. 
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Figure 1: Patient characteristics and their importance in shaping advice HCPs would give to older 
woman (>70) considering continued breast screening (N=139).  
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Table 1.  Statements relating to HCP views on breast screening in older women (n=139). 
 
 Statement n Disagree Neutral Agree 
1 Statements relating to screening benefits     
1.1 
The NHSBSP is a cost effective health 
promotion intervention?  138 8% 37% 55% 
1.2 
The NHSBSP reduces the death rate from 
breast cancer in the screened population? 138 1% 16% 83% 
2 Statements relating to screening harms     
2.1 
The NHSBSP may cause harm by over-
diagnosing cancers/DCIS? 138 25% 16% 59% 
2.2 
The NHSBSP may cause harm by causing 
unnecessary diagnostic procedures? 138 23% 8% 69% 
2.3 
The NHSBSP may cause harm by inducing 
psychological distress? 138 22% 14% 64% 
3 
Statements relating to preferred screening 
organisation in the elderly     
3.1 
There should be selective recall for women 
over 70 who remain in good health?   139 32% 27% 42% 
3.2 
Women >70  should be screened only if 
their GP thought it beneficial?   138 70% 20% 10% 
3.3 
Women should be invited for screening up 
to 80 regardless of health? 139 58% 19% 22% 
3.4 
The NHSBSP should maintain voluntary self 
referral for the >70s? 136 43% 22% 35% 
4 
Statements relating to screening knowledge in 
the elderly     
4.1 
Women over 70 years are more breast 
aware than younger women?  139 80% 16% 4% 
4.2 
Women > 70 are aware that breast 
screening is by self referral?  138 59% 20% 21% 
5 Statements relating to screening age range     
5.1 
Women >70 may not benefit from screening 
as much as women aged 50-69?   139 37% 17% 47% 
5.2 
All women over 50 should be offered 
screening if healthy? 137 19% 12% 69% 
5.3 
Screening should only be offered to age 
range where  cost effective  ? 138 18% 19% 63% 
5.4 
All women > 50 should be screened 
regardless of age ? 128 36% 11% 53% 
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Table 2.   Table summarising the themes from the qualitative health care professional interviews with sample quotes. 
Theme Health Care Professional Interview Quote 
Views regarding breast screening in the over 70s 
Equality of access “I really don’t think it should be up to individual clinicians to say whether a woman should be 
screened”. (GP) 
Cost effective If we are giving the option of something unproven, and potentially unnecessary, we are  diverting 
resources away from, say,  physiotherapy for stroke patients. (Geriatrician) 
Screening should benefit the woman screened Those involved in breast screening should have the right to cease a woman from screening [if she 
won’t benefit]. At the moment we don’t have that privilege. (Radiologist)  
Resource issues of screening more older women The screening units are fairly much at capacity and unless they put more resources into it, it would 
be difficult to screen many more (Breast Surgeon). 
Increased life expectancy  As life expectancy goes up then probably the screening age ought to mimic it. (Breast Surgeon).   
75 is the new 65 (Radiologist) 
Increased breast cancer risk  with age  Age is the biggest risk factor (Breast Care Nurse) 
Predicted life expectancy  Certainly if they are unfit and have limited life expectancy, then it's inappropriate, but if they are 
totally fit and got another 15- 20 years you can’t justifiably turn them down (Breast Surgeon) 
Co-morbidity level I think anybody who is fit for treatment should be screened. (Geriatrician) 
Cognitive function Consenting to the screening process includes being able to understand the consequences of a 
diagnosis of cancer. I think if they can’t consent we shouldn’t make them come. (Radiologist) 
Patient preference Quite a lot of elderly patients ask if they can come back for screening when it ceases (Radiologist).  
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Benefits and risks of breast screening in older age. 
Over diagnosis of cancer   Yes we may over diagnose and we do... But if we leave that low-grade DCIS there is no guarantee that it will 
not progress to high-grade and then invasive disease. So my feeling is that we will cause some psychological 
benefit by the tests that we do to a small proportion of women (Radiologist).  
Psychological distress If you have picked up a very small cancer in a very old lady who is frail and may shortly die from a heart 
attack then you are not really going to have done her any favours by taking her breast off ... All you will have 
done is distress her enormously and caused a lot of pain (Breast Surgeon) 
Unnecessary diagnostic procedures We are looking for smaller and smaller lesions, we are picking up little bits of micro calcification, we are 
bringing women  back for repeat biopsies ... for the detection of smaller and smaller lesions that may never 
even have been invasive cancer. And even if they had been invasive cancer they might never have threatened 
their lives (Radiologist). 
Patient awareness of breast cancer and screening 
Poor awareness of voluntary self referral  I don’t think a lot of older women realise that they are more at risk of developing breast cancer … 
and I think women should know that it is freely available. (Radiologist) 
Reduced breast awareness in older women A misconception that some of the elderly women have is that once they have got to 70, if they haven’t 
developed breast cancer, they  are unlikely to. And I see that quite a bit. Education there is failing them, 
obviously their risk is increasing (Breast Surgeon). 
 
Low impact of screening literature It doesn’t matter how many leaflets you send out, because people don’t read them. (Radiologist) 
Poor patient knowledge of screening risks I don’t think that that people should just be sent for the screening programme without understanding the 
benefits and risks ... I think there needs to be ... counselling, bit of discussion. So that they can make an 
informed decision about whether to go  (Breast Care Nurse) 
Believe themselves at low risk of breast cancer.  They think that because they were told they wouldn’t be sent for anymore, they don’t need 
screening anymore. (Breast Surgeon)  
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Preferred system for screening referral   
Current system may favour higher socio-economic 
groups 
I think it's not necessarily the women who most need screening who are the ones who get it, it's the 
ones who are aware of it, who are more educated, more well read who are then able to access that 
service. (GP) 
Selective recall for healthier older women  You think ‘maybe I shouldn’t be ageist’ ,then ‘maybe I shouldn’t be illnessist‘. It is a very difficult decision. 
You can’t invite a woman but say ‘if you are seriously ill with another condition don’t bother coming’ because 
that is going to cause some significant anxieties about their other medical conditions (Breast Surgeon).  
 
Selectivity a barrier to access. 
 
Why put another barrier in the way. We would want to make it as easy access as possible. 
(Radiologist) 
Current system flawed Is the uptake of screening less in the over 70’s because they have to initiate it themselves? Undoubtedly yes. 
Will a large number forget to arrange it? Almost certainly yes. So for our own programme, the proportion 
screened over the age of 70 is much, much smaller than the proportion of the population below 70. So if you 
are saying screening over 70 is good, does the current system encourage that? Not particularly (Breast 
Surgeon. 
Time, capacity and workload issues of HCP input 
into selective invitation   
Our workload in general practice is getting more and more.  I’m certainly reticent about putting in 
another visit to the GP to discuss something like that. (GP) 
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Table 3: Observed frequencies from HCP survey for 23 scenarios - three outcomes (N=139) 
 Patient   Breast    
Estimated 
Life  
Preference 
for  
Preference 
for not  
 age  Co- Cancer Functional Cognitive Expectancy Screening Screening Undecided 
Scenario (years) morbidity Risk Status Function In Years#  %  %  % 
1 80-84 None Raised Fully independent Normal >5 46.8 36.7 16.5 
2 70-74 Moderate Raised Fully independent Normal >5 85.6 7.9 6.5 
3 75-79 Mild Normal Moderate dependency Severe impairment <2 7.9 79.1 12.9 
4 70-74 None Raised Mild dependency 
Moderate 
impairment 
 
2-5 42.4 37.4 20.1 
5 50-69 None Raised Mild dependency Mild impairment >5 93.5   6.5 
6 80-84 Severe Raised Moderate dependency Severe impairment <2 2.9 93.5 3.6 
7 75-79 Moderate Normal Mild dependency 
Moderate 
impairment 
 
2-5 21.6 62.6 15.8 
8 85+ Moderate Normal Moderate dependency Mild impairment <2 10.1 82.0 7.9 
9 75-79 None Raised Mild dependency Normal >5 74.8 13.7 11.5 
10 85+ Severe Normal Mild dependency Normal <2 7.9 87.8 4.3 
11 50-69 Mild Normal Fully independent Normal >5 97.1 1.4 1.4 
12 50-69 None Normal Fully independent Normal >5 95.7 2.2 2.2 
13 70-74 Severe Normal Severe dependence Normal <2 13.7 74.8 11.5 
14 80-84 None Normal Fully independent 
Moderate 
impairment 
 
<2 24.5 57.6 18.0 
15 50-69 Moderate Raised Severe dependence Severe impairment <2 26.6 56.8 16.5 
16 80-84 Moderate Normal Mild dependency Normal 2-5 33.8 51.8 14.4 
17 70-74 Mild Normal Fully independent Mild impairment >5 74.8 10.8 14.4 
18 85+ Mild Raised Severe dependence 
Moderate 
impairment 
 
<2 7.2 86.3 6.5 
19 75-79 Severe Raised Mild dependency Mild impairment 2-5 24.5 61.9 13.7 
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20 80-84 Mild Raised Moderate dependency Normal 2-5 41.7 39.6 18.7 
21 70-74 None Normal Moderate dependency Severe impairment <2 14.4 66.9 18.7 
22 85+ None Normal Moderate dependency Severe impairment <2 3.6 93.5 2.9 
23 50-69 Severe Normal Moderate dependency 
Moderate 
impairment 
 
<2 41.0 39.6 19.4 
#The predicted life expectancy of each patient scenario was NOT shown to questionnaire respondents.  
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Table 4. Influence of all five DCE variables over preferences for breast screening 
(N=139) 
Preference Factor Level 
Relative 
Risk  P-value 95% CI  
       
Not for Breast Cancer Normal 1.00    
screening Risk Raised 0.91 0.501 0.68 1.21 
vs. undecided       
 Patient  50-69 1.00    
 age (years) 70-74 2.49 <0.001 1.61 3.83 
  75-79 3.84 <0.001 2.32 6.35 
  80-84 4.93 <0.001 2.84 8.56 
  >85 16.04 <0.001 9.00 28.60 
       
 Co-morbidity None 1.00    
  Mild 0.95 0.755 0.69 1.31 
  Moderate 1.57 0.004 1.16 2.13 
  Severe 3.24 <0.001 2.16 4.88 
       
 Functional Fully Independent 1.00    
 status Mild dependency 1.03 0.870 0.71 1.49 
  Moderate dependency 1.05 0.797 0.71 1.57 
  Severe dependence 1.61 0.084 0.94 2.76 
       
 Cognitive Normal 1.00    
 function Mild impairment 0.79 0.102 0.60 1.05 
  Moderate impairment 1.40 0.065 0.98 1.99 
  Severe impairment 3.25 <0.001 2.09 5.04 
       
       
For Breast Cancer Normal 1.00    
screening Risk Raised 1.22 0.153 0.93 1.59 
vs. undecided       
 Patient  50-69 1.00    
 age (years) 70-74 0.27 <0.001 0.18 0.41 
  75-79 0.23 <0.001 0.14 0.38 
  80-84 0.10 <0.001 0.06 0.17 
  >85 0.22 <0.001 0.10 0.46 
       
 Co-morbidity None 1.00    
  Mild 1.29 0.119 0.94 1.76 
  Moderate 1.00 0.989 0.75 1.34 
  Severe 0.54 0.013 0.34 0.88 
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 Functional Fully Independent 1.00    
 status Mild dependency 0.68 0.021 0.49 0.94 
  Moderate dependency 0.42 <0.001 0.28 0.62 
  Severe dependence 0.23 <0.001 0.13 0.39 
       
 Cognitive Normal 1.00    
 function Mild impairment 0.49 <0.001 0.36 0.66 
  Moderate impairment 0.30 <0.001 0.21 0.43 
  Severe impairment 0.19 <0.001 0.11 0.34 
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